On Demand | 5th Meeting on Oncology of Diaspora

73
Speakers
2
Days
167
Registrations
18
Sponsors
Certifications are now available!
No available data. Please contact us via an email requesting your certification or call us to help you.

Moderators: I. Boukovinas (GR), G.Douridas (GR)
08.30-08.50 Best Targeted Therapy for First-Line Gastroesophageal Cancer: PD-1 Inhibitors, Claudin-18.2 (CLDN18.2) or HER2 Inhibitors? I. Souglakos (GR)
08.50-09.00 Discussion

Moderators: Η. Gogas (GR), K. Linos (US)
09.00-09.20 mRNA Vaccines – Why Does this Work in melanoma and Ηow is it Applicable to other tumors? V. Karantza (US)
09.20-09.30 Discussion

(1) Peri-operative therapy in NSCLC
Moderators: F.I. Dimitrakopoulos (GR), P. Tomos (GR)
Presenter 1: Case 1 P. Economopoulou (GR)
Presenter 2: Case 2 K. Papagiannopoulos (UK)
Presenter 3: Case 3 O. Sismanidou (GR)

E. Panagiotidis (GR), Α. Kotsakis (GR), P. Economopoulou (GR), K. Papagiannopoulos (UK), K. Iliadis (GR), E. Gkika (DE), I. Georgakopoulos (GR), E. Tsaroucha (GR)

(2) PSMA-positive mCRPC: How to define the sequence of the Treatment (60 min)
Moderators: K. Koutsoukos (GR), P. Tsantoulis (SUI)
Presenter 1: Case 1 A. Andrikopoulou (GR)
Presenter 2: Case 2 I. Binas (GR)

C.Markellos (GR), E.Skoura (GR), P.Skarlos (GR)

Moderators: A. Nikolaidi (GR), M. Liontos (GR)
PARPi for all in front line ovarian cancer? R. Zakopoulou (GR)

Moderators: A. Kotsakis (GR), F.I. Dimitrakopoulos (GR)
12.30-12.50 PD-L1 <1%: Is this the Place for CTLA-4 Inhibition in Lung Cancer? I. Mountzios (GR) 12.50-13.10 STK11 and Associated Biomarkers: Ready for Primetime or Need More Time? S. Gennatas (UK) 13.10-13.30 ADCs: The New Emperor or the Emperor’s New Clothes? D. Papadatos-Pastos (UK) 13.30-13.50 SCLC: Where we stand and what will be the future therapeutic evolution? A. Kyriazoglou (GR) 13.50-14.10 Discussion

Moderators: I. Souglakos (GR), I. Athanasiadis (GR)
15.10-15.30 Short-Course vs. Long-Course Neoadjuvant Radiation Therapy in Rectal Cancer and strategies for organ preserving and quality of life C. Christopoulos (FR)
15.30-15.40 Q&A
15.40-16.00 New Frontiers for Immunotherapy in Hepatocellular Carcinoma D. Papamichael (CY)
16.00-16.10 Q&A

Moderators: E. Lianidou (GR), P. Kosmidis (GR)
Detecting cancer early with molecular tests N. Papadopoulos (US)

Moderators: G. Vasmatzis (US), V. Anagnostou (US)
Presenter: 2 cases G. Vasmatzis
Presenter: 2 cases V. Anagnostou (US) & K. Karaindrou (US)
Presenter: 1 case O. Sismanidou (GR)

Moderators: Ch. Christodoulou (GR), T. Mamounas (US)
Presenter 1: Neoadjuvant treatment in HR +/HER2- breast cancer A. Papatheodoridi (GR)
Presenter 2: Managing the Patient with High-Risk gBRCA-Mutated HR+/HER2- Early-Stage Breast Cancer T. Mamounas (US)

V.Barbounis (GR), S. Douvetzemis (GR), T. Mamounas (US), G. Nasioulas (GR)

Moderators: E. Lianos (GR), Ph. Koinis (GR)
19.10-19.30 Best treatment upfront in urothelial cancer A. Drakakis (US)
19.30-19.40 Q&A
19.40-20.00 Treatment of Special renal cancer histotypes D. Dalianis (GR)
20.00-20.10 Q&A

Moderators: A. Zygogianni (GR), I. Athanasiadis (GR)
08.50-09.10 New Developments in Locoregional Therapy After Neoadjuvant Chemotherapy T. Mamounas (US)
09.10-09.20 Q&A
09.20-09.40 The Evolving Tool Box in Advanced HR+/HER2- Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond V. Kaklamanis (US)
09.40-09.50 Q&A
09.50-10.10 Immunotherapy in breast cancer: where we are? M. Ignatiadis (ΒΕ)
10.10-10.20 Q&A

Moderators: V. Sioulas (GR), A. Koutras (GR)
10.20-10.40 Precision Oncology: Implementation and new drug development A. Tsimberidou (US)
10.40-10.50 Q&A
10.50-11.10 Cervical Cancer is a Preventable Disease: State of the Art of screening and Vaccination and Future Challenges Th. Agorastos (GR)
11.10-11.20 Discussion

Moderators: N. Papadopoulos (US), L. Tsimberidou (US)
11.50-12.10 Is ctDNA Ready for Prime Time for the Detection of Minimal/ Molecular Residual Disease? M. Liu (US)
12.10-12.20 Q&A
12.20-12.40 The transformative impact of AI in a digital pathology lab K. Linos (US)
12.40-12.50 Q&A
12.50-13.10 Synthetic Lethality: The possibility of developing new strategies in the future S. Linardopoulos (UK)
13.10-13.20 Q&A

Moderators: P. Anastasiadis (US), A. Angeli (GR)
Oncology trends in Pharma S. Stergiopoulos (GR)

Moderator: A. Koumarianou (GR)
Long-term survival benefit of IO combinations. The example of HCC and BTC G. Papaxoinis (GR)

Moderators: V. Georgoulias (GR), S. Karagiannis (UK)
Turning Cold Tumors Hot G. Coukos (SUI)

Moderators: S. Karagiannis (UK), I. Pateras (GR)
16.30-16.50 Hepatic metabolism and the systemic host response to tumours D. Anastasiou (UK)
16.50-17.00 Q&A
17.00-17.20 Monoclonal antibodies for the treatment of solid tumours: insights from studying the circulating and tumour-resident immune response S. Karagiannis (UK)
17.20-17.30 Q&A

Moderators: P. Christopoulos (DE), G. Carystinos (GR), G. Kapetanakis (GR)
18.00-18.50 Initiatives of EU in rare cancers (Grants from EU) I. Boukovinas (GR)
18.50-19.00 Q&A
19.00-19.20 The French national network dedicated to rare gynecological cancer A. Patrikidou (FR)
19.20-19.30 Q&A
19.30-19.50 Retroperitoneal Sarcoma Surgery in the Modern Era D. Tzanis (FR)
19.50-20.00 Q&A

Moderators: I. Souglakos (GR), P. Anastasiadis (US), A. Digklia (CH)
20.00-20.20 Personalized treatment in resistant tumours G. Vasmatzis (US)
20.20-20.40 MRD in Urothelial Cancer P. Grivas (US)
20.40-20.50 Q&A

Agorastos Th.
Prof. of Obstetrics and Gynecology, Aristotle University Thessaloniki, President of the Hellenic HPV Society, Thessaloniki, Greece
Anastasiadis P.
PhD, Professor of Cancer Biology, Deputy Director: May o Clinic Cancer Center, Rochester, USA
Anastasiou D.
Senior Group Leader, The Francis Crick Institute, London, UK
Andrikopoulou A.
Resident in Medical Oncology, Department of Clinical Therapeutics, Alexandra Hospital, Athens, Greece
Angeli A.
Chief Portfolio Value Officer, Roche (Hellas) SA
Athanasiadis I.
Medical Oncologist, Director of Oncology Clinic Mitera Hospital (Hygeia Group), Athens, Greece / Ass. Professor of Oncology, Northwestern University, Chicago, USA
Barbounis V.
MD, PhD, Medical Oncologist, Director of the 3rd Oncology Clinic, Metropolitan Hospital, Piraeus, Greece
Binas I.
Medical Oncologist, 2nd Oncology Clinic, Metropolitan Hospital, Athens, Greece
Boukovinas I.
MD, PhD, PharmaD, Medical Oncologist, Head of Oncology Unit, Bioclinic Thessaloniki, Greece
Carystinos G.
Partner, Health and Life Sciences Sector Leader, EY Greece
Christodoulou C.
Director, 2nd Oncology Clinic, Metropolitan Hospital, Piraeus, Greece
Christopoulos P.
MD, PhD, Hematologist / Medical Oncologist, Thoraxklinik and National Center for Tumor Diseases (NCT) at Heidelberg University Hospital, Heidelberg, Germany
Christopoulos C.
Radiation Oncologist, Head of R adiation Oncology Department, Groupe Hospitalier de Territoire Grand Paris Nord-Est, Paris, France
Coukos G.
Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Switzerland
Dalianis D.
MD, f. Ass. Prof. Internal Medicine - Medical Oncology, U.T. - M.D. Anderson Cancer Center, Director, 1st Medical Oncology Dept. Euroclinic of Athens, Greece
Digklia A.
MD, MSc, Consultant Oncologist, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland
Dimitrakopoulos F. I.
MD, PhD, Medical Oncologist, Division of Oncology & Molecul ar Oncology Laboratory, Department of Medicine, Univ ersity of Patras, Greece
Douridas G.
MD, PhD, Director of Department of Surgery Thriassio Hospital, Attiki, Greece
Douvetzemis Stergios
MD, PhD, FRCS, FEBS, Director Breast Surgeon, Metropolitan General Hospital Athens, Honorary Senior Lecturer, King’s College London, Honorary Consultant Oncoplastic Breast Surgeon, Guy’s and St Thomas’ NHS Foundation Trust London, UK
Drakakis A.
MD, PhD, Associate Professor of Medicine and Urology, Director - Genitourinary Medical Oncology Program, Co-Director of Research, GU Clinical Trials Program, Division of Hematology/Oncology and Institute of Urologic Oncology, UCLA Health, Los Angeles, California
Economopoulou P.
MD, PhD, Consultant Medical Oncologist, 2nd Department of Internal Medicine, Attikon University Hospital, Greece
Gennatas S.
Consultant Medical Oncologist, Guy’ s and St. Thomas ’ NHS Foundation T rust, London, UK
Georgakopoulos I. I.
Assistant Professor of Radiation Oncology, National and Kapodistrian University of Athens, Aretaieion University Hospital, Athens, Greece
Georgoulias V.
Emeritus Professor of Medical Oncology, School of Medicine, University of Crete, Heraklion, Crete, Greece
Gkika E.
Assoc. Professor, Vice Chair of the department of Radiation Oncology, Universitätsklinikum Freiburg, Freiburg, Germany
Gogas H.
Professor of Medical Oncology, 1st Department of Medicine, Laiko Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
Grivas P.
MD, PhD, Associate Professor, Department of Medicine, Division of Medical Oncology, Clinical Director, Genitourinary Cancers Program, University of Washington, Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center, USA
Ignatiadis M.
Associate Professor, Department of Medical Oncology, Institut Bordet, Université Libre de Bruxelles Chair, Breast Cancer Group, EORTC
Iliadis K.
Thoracic Surgeon, Director, Thoracic Surgery Department, Hygeia Hospital, Athens
Kaklamanis V.
MD, DSc, Professor of Medicine, Ruth McLean Bowman Bowers, Chair in Breast Cancer Research and Treatment, A.B. Alexander Distinguished Chair in Oncology, Leader, Breast Oncology Program, UT Health San Antonio, MD Anderson Cancer Center, USA
Kapetanakis G.
President, Hellenic Cancer Federation - ELLOK
Karagiannis S.
Professor of Translational Cancer Immunology and Immunotherapy, St. John’s Institute of Dermatology, School of Basic & Medical Biosciences , King’s College London, Guy’s Hospital, London, UK
Karatza V.
MD, PhD, AVP, Global Clinical Dev elopment, Women’s Cancers, Sub-Section Head for Breast Cancer, Merck, Sharp & Dohme, USA
Koinis F.
MD, PhD, Assistant Professor of Medical Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
Kosmidis P.
MD, Director, 2nd Department of Medical Oncology, Hygeia Hospital, Athens, Greece
Kotsakis A.
MD, PhD, Associate Professor of Medical Oncology, Director of Department of Medical Oncology, University Hospital of Larisa, Thessaly, Greece
Koumarianou A.
MD, PhD, Consultant in Medical Oncology, Hematology Oncology Unit, 4th Department of Internal Medicine, Attikon Univ ersity Hospital, Athens
Koutras Α.
Associate Professor of Medical Oncology, Medical School, University of Patras, Head of the Division of Oncology, Department of Medicine, University Hospital of Patras, Greece
Koutsoukos K.
MD, MCs, Medical Oncologist, Alexandra Hospital, National Kapodistrian University of Athens, Eugenideio Hospital, Athens
Kyriazoglou A
MD, PhD, Medical Oncologist, National & Kapodistrian University of Athens, 2nd Propaedeutic Department of Medicine, Attikon University Hospital, Athens, Greece
Lianidou E.
Professor of Analytical Chemistry - Clinical Chemistry, Analysis of Circulating Tumor Cells (ACTC) Lab, Dept of Chemistry, University of Athens, Athens, Greece
Lianos E.
MD, Medical Oncologist, Sr Consultant - Medical Oncology Dpt., METAXA Memorial Cancer Center Hospital, Piraeus - Greece
Linardopoulos S.
Associate Director, Translational Science, Oncology AstraZeneca - Professor of Cancer Therapeutics, The Insitute of Cancer Research, London, UK
Linos K.
MD, FCAP, FASDP, Associate Professor of Pathology, Geisel School of Medicine at Dartmouth, USA, Bone & Soft Tissue pathology and Dermatopathology Division, Director of Bone & Soft Tissue Pathology Division, Dartmouth Hitchcock Medical Center , USA
Liontos M.
PhD, Medical Oncologist, Consultant, Department of Clinical Therapeutics, Alexandra Hospital, Athens, Greece
Liu M.
MD, Chief Medical Officer for Oncology, Natera, Inc., USA
Mamounas T.
Professor of Surgery, University of Central Florida College of Medicine, Medical Director of Comprehensive Breast Program, Orlando Heath Cancer Institute, Orlando, FL/ Clinical Professor of Clinical Sciences, Florida State University College of Medicine, USA
Markellos C.
Medical Oncologist, Athens Medical Center, Marousi, Athens
Mountzios I.
Consultant-Medical Oncologist, 2 nd Oncology Department and Clinical T rials Unit, Henry Dunant Hospital, Oncolife Institute Founder
Nasioulas G.
PhD, Chief Scientific Officer, Genekor Medical S.A., Athens, Greece
Nikolaidi A.
Medical Oncologist, Mitera Hospital (Hygeia Group), Athens, Greece
Panagiotidis E.
MD, MSc, PhD, FEBNM, Consultant Nuclear Medicine, PET/CT Theageneio Center, Thessaloniki Greece
Papadatos – Pastos D.
MRCP (UK) PhD, Consultant in Medical Oncology, Lung Cancer and Acute Oncology, University College London Hospitals and The Princess Alexandra Hospital, London, UK
Papadopoulos N.
Ph.D., Professor, Oncology and Pathology, Director of Translational Genetics, Ludwig Center for Cancer Genetics & Therapeutics, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Institutions
Papagiannopoulos K.
Senior Consultant Thoracic Surgeon Leeds, Honorary Senior Lecturer Leeds University, Past President and Treasurer European Society of Thoracic Surgeons, Director Central Fund Archdiocese of GB and Thyateira
Papamichael D.
MB, BS, MD, FRCP, Consultant Medical Oncologist, Director – Department of Medical Oncology, Bank of Cyprus Oncology Centre / Associate Professor, St. George’s Hospital and Medical School, University of London, UK
Papatheodoridi A.
Medical Oncology Resident, General Hospital of Athens Alexandra, Athens, Greece
Papaxoinis G.
Consultant Medical Oncologist, Agios Savvas Anticancer Hospital, National and Kapodistrian University of Athens, Greece
Pateras I.
Bsc, MD, PhD, Pathologist, Assistant Professor, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Patrikidou A.
Consultant Medical Oncologist, Genitourinary Oncology Group , Department of Cancer Medicine, Gustave Roussy Institute, University of Paris Saclay, Villejuif, France
Sioulas V.
MD, PhD, Gynecologic Oncologist (Memorial Sloan Kettering Cancer Center, NY, USA), Graduate of Surgical Leadership Program (Harvard Medical School, Boston, USA), Chairman of the 1st Department of Gynecologic Oncology at MITERA Hospital, Chairman of the Scientific Board at MITERA Hospital, Athens, Greece
Sismanidou O.
Medical Oncologist, Bioncology Care, Bioclinic Thessaloniki, Greece
Skarlos P.
MD, PhD, Director of B’ Radiation Oncologly Clinic, Metropolitan Hospital, Neo Faliro, Piraeus
Skoura E.
MSc, PhD, Nuclear Medicine Physician, Head of PET/CT, Henry Dunant Hospital Center, Athens, Greece
Souglakos I.
Associate Professor of Medical Oncology, Laboratory of Translational Oncology, Faculty of Medicine, University of Crete, Department of Medical Oncology, University Hospital of Heraklion, Crete, Greece
Tomos P.
Professor of Thoracic Surgery, Director of Thoracic Surgery Unit, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Greece, Scientific Officer Eugenideio Hospital, Athens, Greece
Tsantoulis P.
MD, PhD, Medical Oncologist, Department of Oncology, Univ ersity Hospital of Geneva, Center for Translational Oncohematology, University of Geneva (HUG), Swiss Cancer Center Leman, Geneva, Switzerland
Tsaroucha E.
MD, MSc, PhD, Pulmonologist - Intensivist, Director of NHS, 2nd Pulmonary Department, Athens Chest Hospital “Sotiria”, Athens Greece
Tsimperidou A.
MD, PhD, Department of Inv estigational Cancer Therapeutics, Division of Cancer Medicine, MD Anderson Cancer Center, USA
Tzanis D.
MD, PhD, Department of Surgery, Institut Curie, Paris, France
Vasmatzis G.
Co-director of the Biomarker Discov ery Laboratory, Mayo Clinic Center for Individualized Medicine, Full Consultant in the Department of M olecular Medicine, Member of the Mayo Clinic Cancer Center, Rochester, USA
Zakopoulou R.
MD, PhD, Medical Oncologist, National and Kapodistrian University of Athens, 2nd Propaedeutic Department of Medicine, A TTIKON University Hospital, Athens, Greece
Zygogianni A.
Associate Professor of Radiation Oncology, University of Athens, Greece

Technical Support is available:
- everyday 09:00-17:00
- at the day of the event 09:00-21:00
For Technical Support please contact us:
Phone: +30 210 72 40 039
Email: support@livetime.gr

Event Details
Sponsors